This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: The University of Nantes, Other. Active years: 2016.
Company Filing History:
1 out of 156 
1 out of 834,411 Years Active: 2016
Title: Stéphane Teletchea: Innovator in Peptide Research
Introduction
Stéphane Teletchea is a notable inventor based in Bouguenais, France. He has made significant contributions to the field of peptide research, particularly in the context of medical applications. His work focuses on the treatment and prevention of diseases related to the RANKL-RANK signaling pathway.
Latest Patents
Stéphane Teletchea holds a patent for "Peptides targeting receptor activator of nuclear factor-κB (RANK) and their applications." This invention relates to a polypeptide that can be used as a medicament for treating and preventing diseases where the RANKL-RANK signaling pathway is involved, especially in bone resorptive diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Stéphane has worked with various institutions, including the Université de Nantes. His research has contributed to advancements in understanding and treating diseases linked to bone health.
Collaborations
Stéphane has collaborated with notable individuals in his field, including Dominique Heymann and Verena Stresing. These partnerships have enhanced the impact of his research and innovations.
Conclusion
Stéphane Teletchea is a prominent figure in peptide research, with a focus on medical applications that address significant health issues. His contributions continue to influence the field and pave the way for future innovations.